India, Oct. 27 -- A healthcare stock remained in focus after the company announced plans to evaluate key shareholder reward proposals, including a potential bonus issue and interim dividend. Investors responded positively to the development, viewing it as a sign of strong financial health and management confidence ahead of the company's second-quarter results.

Dr. Lal PathLabs Ltd, with a market capitalization of Rs. 26,125.39 crore, opened at Rs. 3,110.95 on the BSE against the previous close of Rs. 3,044.50. The stock touched an intraday high of Rs. 3,194, marking a rise of 4.91 percent from its previous close.

What's the News? Dr. Lal PathLabs announced that a meeting of its Board of Directors will be held on Friday, October 31, 2025...